We are live on ! Find out more
FPRX

Five Prime Therapeutics, Inc.
FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

Back to rankings

128 hedge funds and large institutions have $555M invested in Five Prime Therapeutics, Inc. in 2018 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 66 increasing their positions, 15 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

340% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 15

3% less capital invested

Capital invested by funds: $573M → $555M (-$17.8M)

7% less funds holding

Funds holding: 137 → 128 (-9)

21% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 28

55% less call options, than puts

Call options by funds: $1.22M | Put options by funds: $2.73M

Holders
128
Holders Change
-9
Holders Change %
-6.57%
% of All Funds
2.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
66
Reduced
15
Closed
28
Calls
$1.22M
Puts
$2.73M
Net Calls
-$1.51M
Net Calls Change
-$12K

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$30.4M
2
EC
EcoR1 Capital
California
+$24.2M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$17.4M
4
GPP
Great Point Partners
Connecticut
+$16.9M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$16.6M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$9.88M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$9.75M
3
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
-$6.94M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$5.05M
5
Morgan Stanley
Morgan Stanley
New York
-$5.01M
Name Holding Trade Value Shares
Change 		Change in
Stake
Axa
26
Axa
France
$3.79M +$1.71M +87,548 +66%
AAMU
27
Amundi Asset Management US
Massachusetts
$3.48M – – –
Two Sigma Advisers
28
Two Sigma Advisers
New York
$3.37M +$2.58M +132,300 +208%
Balyasny Asset Management
29
Balyasny Asset Management
Illinois
$3.29M -$5.05M -258,911 -58%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$2.9M +$361K +18,496 +12%
ARTA
31
A.R.T. Advisors
New York
$2.73M +$127K +6,500 +4%
Charles Schwab
32
Charles Schwab
California
$2.63M +$461K +23,616 +18%
Alyeska Investment Group
33
Alyeska Investment Group
Illinois
$2.55M +$2.9M +148,661 New
Two Sigma Investments
34
Two Sigma Investments
New York
$2.12M -$345K -17,673 -13%
EAM
35
Eventide Asset Management
Massachusetts
$1.8M -$4.1M -210,000 -67%
Bank of America
36
Bank of America
North Carolina
$1.73M +$1.07M +54,822 +120%
Hudson Bay Capital Management
37
Hudson Bay Capital Management
Connecticut
$1.72M +$1.95M +100,000 New
UBS Group
38
UBS Group
Switzerland
$1.7M +$1.7M +87,363 +774%
UBS AM
39
UBS AM
Illinois
$1.66M – – –
Morgan Stanley
40
Morgan Stanley
New York
$1.63M -$5.01M -256,961 -73%
State of Wisconsin Investment Board
41
State of Wisconsin Investment Board
Wisconsin
$1.62M +$1.45M +74,507 +373%
PIM
42
Platinum Investment Management
Australia
$1.62M +$613K +31,400 +50%
AGA
43
Altrinsic Global Advisors
Connecticut
$1.55M +$195K +10,000 +13%
VIA
44
Vident Investment Advisory
Georgia
$1.41M +$425K +21,779 +36%
CS
45
Candriam SCA
Luxembourg
$1.37M – – –
TAM
46
Trillium Asset Management
Massachusetts
$1.36M +$394K +20,220 +34%
Citadel Advisors
47
Citadel Advisors
Florida
$1.29M -$154K -7,920 -10%
TCIM
48
TIAA CREF Investment Management
New York
$1.26M +$186K +9,514 +15%
BIM
49
Bogle Investment Management
Massachusetts
$1.23M +$1.4M +71,552 New
AIM
50
ARK Investment Management
Florida
$1.18M +$500K +25,639 +59%
1
2
3 4 5

FPRX Hedge Fund Activity: Q1 2018 in Review

128 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q1 2018, worth a combined $555M — down 3.1% from $573M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of FPRX and 22 opened new positions — a net loss of 6 holders — while 15 trimmed existing stakes and 66 added.

The largest buyer was Wellington Management Group, adding an estimated $30.4M. The largest seller was Deerfield Management, exiting entirely with an estimated $9.88M sold.

  • 128 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q1 2018, down from 137 in Q4 2017.
  • Funds reported $555M of Five Prime Therapeutics, Inc. stock for Q1 2018, down 3.1% quarter-over-quarter.
  • 22 funds opened new Five Prime Therapeutics, Inc. positions in Q1 2018 and 28 closed out, a net change of -6 holders.
  • The largest Five Prime Therapeutics, Inc. buyer in Q1 2018 was Wellington Management Group, an estimated $30.4M added.
  • The largest Five Prime Therapeutics, Inc. seller in Q1 2018 was Deerfield Management, an estimated $9.88M sold.

Based on aggregated 13F filings for Q1 2018.